Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Create Stock SIPAutomate your investments in this
Performance
Open
741.00Prev. Close
737.05Volume
47,150Total traded value
3.67 CrUpper Circuit
933.20Lower Circuit
622.20Fundamentals
| Market Cap | ₹1,638Cr |
| ROE | 12.60% |
| P/E Ratio(TTM) | 24.33 |
| EPS(TTM) | 31.94 |
| P/B Ratio | 3.07 |
| Dividend Yield | 0.74% |
| Industry P/E | 33.07 |
| Book Value | 253.39 |
| Debt to Equity | 0.06 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Windlas Biotech
Headquartered in Dehradun, Windlas Biotech Limited is a prominent Contract Development and Manufacturing Organization (CDMO) within India's pharmaceutical landscape, known for delivering high-quality healthcare solutions. The company's vision is to be recognized as a premier partner of choice in the Indian pharmaceutical contract development and manufacturing sector. It aims to serve society's unmet healthcare needs by producing high-quality products and developing innovative solutions that enhance the affordability of medicines for all. Its business presence is strategically focused on three core areas: the Generic Formulations CDMO vertical, the Trade Generics & Institutional vertical, and the Exports vertical. Through its CDMO vertical, the company serves the manufacturing needs for 16 of the top 20 pharmaceutical companies in India, showcasing its strong industry partnerships. In the last fiscal year, Windlas Biotech registered a remarkable 20% increase in revenue, outpacing the overall industry growth and reaffirming its strong strategic execution.;
| Parent Organisation | Windlas Biotech |
| Managing Director | Komal Gupta |
| Founded | 2001 |
| NSE Symbol | WINDLAS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.10 | ||
| Ajanta Pharma | NA (0.00%) | 33.65 | ||
| Gland Pharma | NA (0.00%) | 34.84 | ||
| Eris Lifesciences | NA (0.00%) | 47.73 |
2025
6
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
21JulDividendEx date₹5.80per share
21
Jul
Dividend
Ex date
₹5.80
per share
For each share you hold, you will receive ₹5.80
Dividend amount₹5.80 per share
Dividend TypeFinal
Ex Date21 Jul ‘25
Record Date21 Jul ‘25
Announcement date22 May ‘25
22MayDividendAnnounced₹5.80per share
22
May
Dividend
Announced
₹5.80
per share
For each share you hold, you will receive ₹5.80
Dividend amount₹5.80 per share
Dividend TypeFinal
Ex Date21 Jul ‘25
Record Date21 Jul ‘25
Announcement date22 May ‘25
22
May
Annual Result
Release date
11
Feb
Quarterly Result
Release date
2024
12
Nov
Quarterly Result
Release date
17SepDividendEx date₹5.50per share
17
Sep
Dividend
Ex date
₹5.50
per share
For each share you hold, you will receive ₹5.50
Dividend amount₹5.50 per share
Dividend TypeFinal
Ex Date17 Sep ‘24
Record Date17 Sep ‘24
Announcement date20 May ‘24
13
Aug
Quarterly Result
Release date
20MayDividendAnnounced₹5.50per share
20
May
Dividend
Announced
₹5.50
per share
For each share you hold, you will receive ₹5.50
Dividend amount₹5.50 per share
Dividend TypeFinal
Ex Date17 Sep ‘24
Record Date17 Sep ‘24
Announcement date20 May ‘24
20
May
Result
Release date
Events calendar
View upcoming events in other stocks